On May 11, 2022 Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, reported that company management will present and participate in one-on-one meetings at the following investor conferences in May (Press release, Viracta Therapeutics, MAY 11, 2022, View Source [SID1234614248]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

RBC Capital Markets 2022 Global Healthcare Conference
Presentation Date: May 18, 2022
Presentation Time: 9:00 a.m. EDT
Format: Fireside chat

H.C. Wainwright Global Investment Conference
Presentation Date: May 24, 2022
Presentation Time: 11:30 a.m. EDT
Format: Fireside chat

A live webcast of each presentation will be available on the Investors section of the Viracta website under "Events and Webcasts" at View Source The webcasts will be archived for 30 days.